Invest Telangana

Global Summit 2026

Join global business leaders, policymakers and investors at the Invest Telangana Global Summit 2026. Secure your place through the official registration portal.

Know More

A $3 Trillion Vision

By 2047, Telangana aims to become a $3 trillion economy, fuelled by investment, innovation and inclusive growth.

Read the roadmap

Stay Informed

Explore the latest announcements and G.O.s, decisions, developments and moments shaping Telangana’s growth story.

Clearance is a right, not a favour

TG-iPASS gives every investor a statutory 15-day deadline. Miss it, and approval is deemed granted by law.

How the clock runs
Contact
Contact Explore TG-iPASS
All press releases
Life Sciences

Ciro Pharma invests Rs 800 crore in India’s first integrated oncology manufacturing facility in Hyderabad

Ciro Pharma has opened an Rs 800 crore integrated oncology manufacturing facility at Genome Valley, creating 500 direct jobs in the first phase.

Ciro Pharma has opened what it describes as India’s first integrated oncology manufacturing facility, at Biotech Park Phase III in Genome Valley, Hyderabad. The company has invested Rs 800 crore in the plant, which was inaugurated by Sri D. Sridhar Babu, Minister for IT, Electronics & Communications, Industries & Commerce and Legislative Affairs.

The facility will make oral oncology medicines, sterile injectables, lyophilised powder injections and soft gel capsules, using advanced containment technology suited to cancer therapies.

The unit will create 500 direct jobs in the first phase, and employment is expected to double in the coming years. The investment further strengthens Telangana’s role as a global hub for life sciences and pharmaceutical manufacturing.